Technology in Cancer Research & Treatment (Feb 2023)

Minimally Invasive Treatment in Benign Prostatic Hyperplasia (BPH)

  • L. V. Sciacqua MD,
  • A. Vanzulli MD,
  • R. Di Meo MD,
  • G. Pellegrino MD,
  • R. Lavorato BSc/MSc,
  • G. Vitale MD,
  • G. Carrafiello MD

DOI
https://doi.org/10.1177/15330338231155000
Journal volume & issue
Vol. 22

Abstract

Read online

Review efficacy and safety of minimally-invasive treatments for Low Urinary Tract Symptoms (LUTS) in patients affected by Benign Prostate Hyperplasia (BPH). We performed a systematic review of the literature from 1993 to 2022 leveraging original research articles, reviews, and case-studies published in peer-reviewed journals and stored in public repositories. Prostate artery embolization (PAE), transurethral needle ablation (TUNA), transurethral microwave thermotherapy (TUMT), high intensity focused ultrasound (HIFU), laser treatments and Cryoablation are valid and safe alternatives to the gold standard (surgery) in the treatment of LUTS in patients affected by BPH, with fewer undesired effects being reported.